CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $93,489 | -78.7% | 55,648 | -64.1% | 0.00% | -70.0% |
Q2 2023 | $438,622 | +83.6% | 154,990 | +218.6% | 0.01% | +66.7% |
Q1 2023 | $238,862 | -51.8% | 48,648 | +5.4% | 0.01% | -57.1% |
Q4 2022 | $495,630 | +19.7% | 46,148 | +4.5% | 0.01% | +7.7% |
Q3 2022 | $414,000 | – | 44,170 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 3,193,057 | $51,440,000 | 39.10% |
Chescapmanager LLC | 1,299,701 | $20,938,000 | 3.08% |
Burrage Capital Management LLC | 284,170 | $4,578,000 | 3.07% |
Cypress Capital Management LLC (WY) | 184,085 | $2,966,000 | 2.80% |
DAFNA Capital Management LLC | 328,533 | $5,293,000 | 1.82% |
Mesirow Financial Investment Management, Inc. | 21,169 | $341,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 471,575 | $7,597,000 | 1.14% |
AdvisorShares Investments LLC | 79,821 | $1,286,000 | 0.80% |
ETF MANAGERS GROUP, LLC | 750,680 | $12,093,000 | 0.42% |
FARALLON CAPITAL MANAGEMENT LLC | 2,300,000 | $37,053,000 | 0.25% |